Anika Therapeutics (ANIK) Insider Conley Buys 10,402 Shares

Sheryl Conley recently made a move in the stock market by purchasing 10,402 shares of ANIK on June 18, 2026. This insider transaction was not planned in advance, and the details of the purchase price and total value were not disclosed.

Insider Buying and Selling at Anika Therapeutics, Inc.

Sheryl Conley wasn't the only insider buying ANIK shares. On the same day, several other insiders, including Richard Stephen, Gary Fischetti, Joseph Capper, John Henneman III, and Stephen Griffin, also acquired 10,402 shares each. Stephen Griffin, who is the President and CEO, had previously purchased 12,840 shares on June 3, 2026.

Other Institutional Activity in ANIK

Several institutional investors have been active with ANIK shares. BlackRock, Inc. reduced its holdings by 59,644 shares, leaving it with 1,594,893 shares worth about $23.13 million. Morgan Stanley, on the other hand, increased its position by 99,836 shares, now owning 872,066 shares valued at approximately $12.64 million. Vanguard Capital Management LLC opened a new position with 605,777 shares valued at $8.78 million. Meanwhile, Boothbay Fund Management, LLC slightly trimmed its stake by 5,004 shares, maintaining 529,503 shares worth about $7.68 million.

Anika Therapeutics, Inc. Stock Down 31.8%

Shares of ANIK traded near $14.20 on Wednesday. The stock has seen various institutional activities, reflecting broader market interest. The current trading environment and insider activities might suggest differing views on the company’s future prospects.

Analysts Set New Price Targets

On February 27, 2026, Barrington Research maintained its 'buy' rating on ANIK, setting a price target of $17.00. This consistent 'buy' stance from Barrington Research over several months indicates confidence in the company's potential.

Bottom Line

Sheryl Conley's purchase of ANIK shares, along with similar moves by other insiders, highlights notable activity around the stock. Investors keep an eye on such insider transactions as they can sometimes offer insights into the company’s prospects. However, these transactions are part of regular reporting and may not reflect current positions or future expectations.